- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$292.42 MnMarket Estimate, 2026
$316.81 MnMarket Forecast, 2034
$599.84 MnCAGR, 2026–2034
8.31%Executive Summary: Middle East and Africa Specialty Enzymes Market
- Market Scope: Comprehensive regional analysis of the MEA specialty enzymes sector, covering valuation metrics, sources, types, applications, country breakdown, DROC, and major industry competitors.
- Market Valuation: Valued at USD 292.42 million in 2025, reaching USD 316.81 million in 2026, and projected to scale up to USD 599.84 million by 2034, growing at a robust CAGR of 8.31% from 2026 to 2034.
- Primary Growth Drivers: Rising use of specialty enzymes in advanced diagnostic tests for chronic conditions (cancer, diabetes, heart diseases) and efficiency-driven pharmaceutical manufacturing.
Key Market Segment Metrics
| Category | Leading Sub-Segment (2025/2026 Base) | High-Growth / Core Segment Focus |
|---|---|---|
| By Source | Microorganisms (Dominates due to scalable fermentation, cost efficiency, and high enzyme yield) | Plant & Animal Sources (Niche applications in specialized therapeutic and dietary uses) |
| By Type | Proteases & Carbohydrases (Extensively utilized across pharmaceutical formulations and diagnostic tests) | Polymerases & Nucleases (Accelerating rapidly with molecular diagnostics and biotech research) |
| By Application | Pharmaceuticals & Diagnostics (Led by disease diagnosis, oncology, diabetes, and drug synthesis) | Research & Biotechnology (Fueled by genomic sequencing and advanced life sciences labs) |
| By Country / Region | GCC Countries (KSA, UAE) & South Africa (Drive the highest regional consumption via advanced healthcare) | Rest of MEA (Emerging markets expanding via rising healthcare and agricultural investments) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive landscape driven by R&D investments, regulatory compliance (FDA/CVM approvals), and strategic customization of biocatalysts for pharma and agricultural applications.
Key Companies: Novonesis, BASF SE, DSM-Firmenich, DuPont de Nemours, Inc., Associated British Foods plc, Kerry Group plc, Advanced Enzyme Technologies Ltd., Amano Enzyme Inc., Codexis, Inc., and AB Enzymes GmbH.
Download Free Sample Report
Middle East and Africa Specialty Enzymes Market Size
The Middle East and Africa specialty enzymes market size was valued at USD 292.42 million in 2025 and is anticipated to reach USD 316.81 million in 2026 from USD 599.84 million by 2034, growing at a CAGR of 8.31% during the forecast period from 2026 to 2034.
The rising use of specialty enzymes in various diagnostic tests for cancer, diabetes, and heart diseases is a key driver driving the growth of the Middle East and Africa specialty enzymes market. In addition, specialty enzymes also aid in the production of low-cost medications and treatments by increasing manufacturing efficiencies. Therefore, the increasing demand for non-harmful biological catalysts in pharmaceuticals and diagnostics is expected to boost the market growth in MEA. On the other hand, the usage of specialized enzymes in fine chemicals as a biocatalyst for rapid reactions is a significant factor driving the Middle East and Africa specialty enzymes market over the forecast period.
The use of specialty enzymes increased significantly throughout the forecast period due to the increasing use of new techniques to optimize pharmaceutical production and people's concerns about quality. Moreover, the multifunctional benefits of specialty enzymes in various applications and technological developments to reduce the consumption of chemical catalysts are propelling the specialty enzyme market forward. In addition, custom enzymes have grown in popularity due to the development of tools to optimize pharmaceutical production and customer concerns about quality.
Specialty enzymes have a wide range of applications throughout the region; however, the leading players use various strategies to expand regional market growth. Furthermore, industry participants are developing advanced and innovative phytase enzymes and insisting on FDA and Center for Veterinary Medicine approval to utilize the product in animal feed diets.
The specialized enzyme market in the MEA region is growing due to the multifunctional benefits of specialty enzymes in various applications and technological advancements that reduce the use of chemical catalysts. Furthermore, specialty enzymes are in great demand because of the increased use of enzymes in pharmaceutical companies. Specialty enzymes are commonly used in the pharmaceutical sector for medicine production, disease diagnosis, and therapy. The rising use of enzymes in cancer, cardiovascular disease, lysosomal storage disorders, and pain and inflammation control is one factor driving the market growth.
However, the high cost of diagnostics solutions for chronic diseases in emerging countries, and the lack of awareness regarding diagnostic tests, on the other hand, are the major factors hampering the specialty enzymes market growth in the MEA region.
KEY MARKET PLAYERS
Some of the promising companies that are playing a dominating role in the Middle East and Africa specialty enzymes market include
- Novonesis
- BASF SE
- DSM-Firmenich
- DuPont de Nemours, Inc.
- Associated British Foods plc
- Kerry Group plc
- Advanced Enzyme Technologies Ltd.
- Amano Enzyme Inc.
- Codexis, Inc.
- AB Enzymes GmbH
MARKET SEGMENTATION
This research report on the MEA specialty enzymes market has been segmented and sub-segmented into the following categories.
By Source
- Microorganism
- Plant
- Animal
By Type
- Protease
- Lipase
- Carbohydrases
- Polymerases
- Nucleases
By Application
- Research & Biotechnology
- Diagnostic
- Pharmaceutical
- Biocatalyst
By Country
- KSA
- UAE
- Israel
- Rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- Rest of MEA